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Recombineering, a recently developed technique for efficient
genetic manipulation of bacteria, is facilitated by phage-
derived recombination proteins and has the advantage of
using DNA substrates with short regions of homology. This
system was first developed in E. coli but has since been
adapted for use in other bacteria. It is now widely used in a
number of different systems for a variety of purposes, and the
construction of chromosomal gene knockouts, deletions,
insertions, point mutations, as well as in vivo cloning,
mutagenesis of bacterial artificial chromosomes and
phasmids, and the construction of genomic libraries has
been reported. However, these methods also can be
effectively applied to the genetic modification of
bacteriophage genomes, in both their prophage and lytically
growing states. The ever-growing collection of fully sequenced
bacteriophages raises more questions than they answer,
including the unknown functions of vast numbers of genes
with no known homologs and of unknown function.
Recombineering of phage genomes is central to addressing
these questions, enabling the simple construction of mutants,
determination of gene essentiality, and elucidation of gene
function. In turn, advances in our understanding of phage
genomics should present similar recombineering tools for
dissecting a multitude of other genetically naïve bacterial
systems.
Introduction
Bacteriophages are extremely abundant, and it has been estimated
that the number of phage particles in the biosphere is approxi-
mately 10
31.
1 These phages are a source of high genetic diversity
and are replete with genetic novelty.
2 They have played key roles
in the development of bacterial genetics and can provide effective
solutions for the development of systems to manipulate genetically
naïve bacteria.
3 Genetic modification of phages can facilitate the
study of these viruses and, in consequence, the development of
new tools for bacterial manipulation.
In contrast to the range of tools that have been described for
targeted mutagenesis of bacterial chromosomes, fewer methods
have been implemented for targeted mutagenesis of lytically
growing phages, because high frequency events are required in the
absence of a selectable system.
Historically, construction of mutations in bacteriophages was
accomplished by general mutagenesis using UV irradiation or
chemical compounds that can generate DNA damage.
A homologous recombination approach has also been used to
make gene deletions or recombinant phages,
4,5 but the frequency
is low and screening to find the desired mutant can be tedious
and time consuming.
Recently, a new in vivo technology to introduce genetic
changes in bacterial genomes has been developed. This
technique—named “recombineering”—refers to the engineering
of recombinant DNA by homologous recombination.
6-8 Recom-
bineering employs recombination systems encoded by bacterio-
phages to enhance the frequency of homologous recombination,
allowing the construction of chromosomal gene knock outs,
deletions, insertions, point mutations, in vivo cloning, mutagen-
esis of bacterial artificial chromosomes, phasmids and genomic
libraries.
6-15
The increased availability of bacterial genome sequences has
facilitated the use of recombineering, because it is only possible to
recombineer an organism whose sequence is known.
The first systems described employed recombination functions
encoded by bacteriophage lambda and the Rac prophage, and
were originally designed for modification of E. coli. Subsequently,
these were successfully employed in other Gram-negative bacteria,
such as Salmonella and Shigella,
16,17 and further adapted for
application to other more divergent bacteria, like the insect
endosymbiont Sodalis glossinidius and the promising subject for
biotechnological exploitation, Pantoea ananatis.
18,19
Double-stranded DNA recombineering in E. coli using the
lambda Red system involves three phage-encoded proteins, Exo,
Beta and Gam. Exo is an exonuclease that degrades one strand
of DNA from a double-stranded end to generate a ssDNA
substrate. Beta is a DNA pairing enzyme that anneals the
recombineering substrate to its chromosomal target. Gam inhibits
the E.coli RecBCD and SbcD enzymes, preventing degradation of
the double-stranded DNA (dsDNA) substrate.
20-23 For optimal
dsDNA recombineering, RecBCD should be inactivated, either
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by mutation or by lambda gam.
6,8,24 The original model proposed
that after degradation by Exo, a 3' single stranded DNA tail is
exposed to which Beta can bind.
8 Homologous recombination
then occurs, following the strand invasion or DNA annealing
model.
25-28 Recently, a new model to explain the mechanism of
dsDNA recombination mediated by lambda phage proteins has
been proposed.
29,30 In this alternative model, lambda exonuclease
entirely degrades one strand, while leaving the other strand
intact as single-stranded DNA. This single-stranded intermediate
then recombines via β recombinase catalyzed annealing at the
replication fork.
The Rac prophage encodes only RecE and RecT, which are
functionally equivalent to lambda Exo and Beta, respectively.
12,31
Beta belongs to a large family of ssDNA annealing proteins
(SSAPs),
32-34 and only this protein is necessary for single-stranded
oligonucleotide recombination,
7 used for the creation of point
mutations and deletions. A strand bias in recombination levels
has been observed when comparing two complementary ssDNAs.
Higher frequencies are obtained when using an oligonucleotide
that anneals to the DNA strand undergoing discontinuous
synthesis (lagging strand). As a result of the replication process,
transient regions of ssDNA may be accessible for Beta-mediated
annealing of the oligo. The increased recombination efficiency
of the ‘‘lagging strand’’ oligos may reflect the increased availability
of single-stranded regions during lagging vs. leading strand
synthesis.
7,12,35
Regulated expression of the bacteriophage recombination
system typically is required for recombineering. These functions
can be integrated into the chromosome or contained within an
extrachromosomal plasmid. A lambda lysogen with a defective
prophage can be used to express the Red proteins from the strong
lambda pL promoter.
6 The recombineering functions have also
been transferred to a variety of different plasmids,
36 including
constructs in which the functions are under control of the
arabinose promoter pBAD.
14 Some plasmids carry a temperature-
sensitive (ts) origin of replication, so they can be cured from the
cell after recombination. The prophage constructs contain the
ts cI857 allele of the phage lambda repressor allowing protein
expression to be controlled by temperature. At low temperature
(30°C), recombineering functions are strongly repressed, and
expression occurs after a shift to 42°C for only 15 min.
The efficiency of recombineering in E. coli and the possibility
of using DNA segments with short regions of homology (approx.
50 bp) to the target sequences has led to the search for proteins
with similarity to the lambda/Rac encoded proteins in other
phages or bacteria, especially because adapting the lambda/Rac
systems for its use in other organisms, particularly those that are
Gram-positive could not give optimal results.
37-39
The complete genome sequences of more than 80 mycobacter-
iophage genomes
40-45 has provided us with thousands of unique
genes, making this an ideal reservoir in which to search for novel
recombineering functions. Recently, RecE and RecT homologs—
the products of genes 60 and 61, respectively—were identified in
mycobacteriophage Che9c, the expression of which substantially
enhances mycobacterial recombination frequencies. These pro-
teins have been utilized to develop an efficient recombineering
system, facilitating the construction of gene-knockouts and point
mutations in the hard to manipulate and pathogenic bacterium
Mycobacterium tuberculosis, as well as in fast-growing related
species like Mycobacterium smegmatis, which is routinely use as a
model system.
46,47
Mycobacterial strains constructed for recombineering contain
an extra chromosomal plasmid in which the phage recombina-
tion genes are under the control of the inducible acetamidase
promoter.
48 Similar to what has been shown in E. coli, dsDNA
recombineering in the mycobacteria requires both an exonuclease
(gp60) and its associated recombinase (gp61),
39 while recom-
bination using ssDNA substrates requires only the recombinase.
47
Targeted gene replacement mutants are engineered using linear
dsDNA allelic exchange substrates (AESs), containing regions of
homology upstream and downstream of the target gene flanking
a cassette for antibiotic resistance, which are electroporated into
either M. smegmatis or M. tuberculosis recombineering strains.
39
Substrates for ssDNA recombineering are short oligonucleo-
tides—a minimum length of 50 bases is recommended—
encoding the desired mutation, and this technique provides a
simple and efficient method for constructing point mutations
in mycobacterial genomes.
47 The overall efficiency of ssDNA
recombineering is substantially higher than with dsDNA sub-
strates for both chromosomal and plasmid targets. However,
optimal efficiencies are only obtained when using oligonucleo-
tides that target, and anneal to, the DNA strand undergoing
discontinuous synthesis (lagging strand template).
47 These can
display efficiencies that are up to 10,000-fold higher than
oligonucleotides targeting the leading strand, which far exceeds
the 2–50 fold strand biases observed in the l Red system.
7,35 It
is not clear why the biases are so much larger in mycobacteria
than in E. coli, but this may reflect fundamental differences in
the DNA replication systems and/or in how gp61 interacts
with the replication machinery and supports the necessity of
finding recombineering systems specific for each bacteria or
related bacterial group.
Recombineering systems based on the mycobacteriophage
Che9c-encoded proteins have provided new approaches to myco-
bacterial mutagenesis and greatly expanded the genetic toolbox
available to study the pathogenic mycobacteria.
Datta et al.
37 have also identified and characterized genes that
are similar to Beta or RecT from Gram-positive and other Gram-
negative bacteria and their phages. Nine genes, including Che9c
gp61, were expressed in E. coli under control of lambda pL,
and protein activity was assayed using an oligo recombination
system.
49 Seven of these nine genes were adjacent to a known or
putative exonuclease gene. In the E. coli system, all the ssDNA
binding proteins tested were able to catalyze oligo-mediated
recombination but with variable efficiency; Che9c gp61 recomb-
ination levels were approximately 1000-fold lower than those
observed with lambda β. When present with their canonical
exonucleases, three of the four recombinase-exonuclease pairs
tested were also able to carry out low level recombination with
linear dsDNA, but not when coupled to lambda Exo; presumably
because a physical and specific coupling is required between the
cognate exonuclease and single strand annealing proteins. Thus,
6 Bacteriophage Volume 2 Issue 1© 2012 Landes Bioscience.
Do not distribute.
the exonuclease seems to be more species-specific, whereas the
recombinase can function in diverse hosts.
After failure to observe lambda Red-mediated recombination in
Pseudomonas syringae, and based on the hypothesis that recom-
binases found in, or associated with, particular species would
be more likely to function in close relatives than distantly
species,
32,50,51 Swingle et al.
38used a combination of bioinformatic
tools to identify proteins homologous to RecE/RecT in Pseudomas
syringae pv syringae B728a. The so-called recTEPSY genes are
located in a 72 kb region that has been horizontally acquired in
Pseudomas syringae pv syringae B728a. This region contains 86
annotated open reading frames (ORFs), the majority of which
encode hypothetical proteins. Thirteen ORFs in this locus are
annotated as phage-related proteins, and it is likely this region
corresponds to a prophage or a remnant of a prophage containing
the recombination functions. Depending on the oligo concentra-
tion, up to a 450-fold difference in recombination frequency
between the RecTPSY expression and vector control strains was
observed. Additionally, dsDNA recombination was observed
when RecTPSY was assisted by RecEPSY.
Recombineering can be used to target the bacterial chromo-
some or extrachromosomal replicating molecules. As a corollary to
this, it also can be extended for efficient and straightforward
modification of bacteriophage genomes. Here, we will discuss the
generation of E. coli phage mutants using recombineering with
lambda Red proteins, as well as the construction of mycobacter-
iophage mutants using BRED (Bacteriophage Recombineering of
Electroporated DNA).
52
Recombineering Prophages
One relatively straightforward approach to engineering phage
genomes is to use dsDNA recombineering to modify an integrated
prophage, effectively treating it as any other chromosomal locus.
There are, however, several limitations and disadvantages. First,
this approach is restricted to temperate phages. Moreover, it is
useful for these to be inducible phages, such that lytically growing
particles of the constructed mutant can be generated. While this is
often not a concern for well-characterized systems such as phage
lambda, it may be generally so. Second, this approach typically
requires the use of a selectable marker to recover the desired
mutant, and introduction of a marker such as a drug resistance
gene can both introduce genetic polarity, and increase the size of
the phage genome beyond a packaging limit. These effects can be
minimized by using a second event—such as by using site-specific
recombination—to remove the selectable marker, but this then
requires multiple sequential manipulations. Strategies to modify
an integrated prophage are described in more detail below.
Recombineering E. coli Phages
E. coli phage mutants have played key roles in the study of
phage biology,
53-57 but the construction and/or screening of the
desired mutation can be tedious and time consuming. Recom-
bineering has simplified mutant phage construction, by increas-
ing the frequency of recombination events in the cell, enabling
the engineering of lytically growing phages. This should be
applicable to all or most phages that can be propagated in the
laboratory and avoids the need for genetic selection and the
associated problems with genetic polarity. Two main approaches
to recombineering lytically growing phages have been described,
one using phage lambda as a model system, and the second using
mycobacteriophages as a model system.
A method for engineering phage lambda was originally
described by Oppenheim et al.
58-60 In general, this involves
infecting cells with phage, preparing competent cells, introducing
the dsDNA or ssDNA substrates by electroporation and analyzing
the resulting plaques for the presence of the mutation. A scheme
of the general strategy used to modify phages infecting E. coli
is shown in Figure1. Because this method relies on physical
screening to identify the desired mutants, it is critical that not
only the recombination frequency is high, but that the electro-
poration efficiency is also very high (which is true for E. coli), such
that a very high proportion of cells take up the dsDNA or ssDNA
substrate.
Although most of the strains carrying the defective lamboid
prophage expressing β, exo and gam are W3110 or MG1655
derivatives, the prophage can be moved to other backgrounds by
P1 transduction,
6,61,62 or the desired strain can be transformed
with a plasmid expressing the recombination functions.
36 For that
reason, with some modifications, this protocol originally deve-
loped for lambda phage, can be adapted to make mutations in
most E. coli phages. Alternatively, an intact prophage can serve as
both the source of the recombination functions and the target for
recombineering. In this case, not only must the recombination
functions be present, the prophage must also be inducible in
order to recover phage particles after recombineering.
In both cases, cells are grown to exponential phase. If a lytically
growing phage is going to be modified, the cells are infected at a
multiplicity of infection (MOI) of 1–3 and left standing to allow
the phage adsorb (adsorption conditions for each phage must be
taken in consideration for this step). This is not necessary if the
phage is already present as a prophage in the cells.
In the next step, expression of Beta, Exo and Gam (when it is
present) is induced for a short period of time. Conditions for
induction have to be determined on the basis of the selected
strain (temperature shift, addition of the inducer, etc.). The cells
are then gently washed, and the appropriate DNA substrate is
introduced by electroporation. When modifying an intact pro-
phage, full induction time should only be used if the prophage
is going to be induced and a recombinant lysate prepared. The
progeny phage must then be screened for the mutation. Alter-
natively, the prophage may be targeted using a selectable marker,
such as a drug resistance cassette, and the recombinant bacterial
colonies identified using selection (see below).
A single-stranded oligo or a dsDNA PCR product can be used
as substrate for bacteriophage recombineering (Fig.2). When a
ssDNA substrate is used (for base substitution or small deletions
or insertions), these are typically about 70 bases in length and are
designed such that the alteration to be introduced is contained in
the center of the oligo. An 80-nucleotide oligo was successfully
used to generate a 326 bp deletion of the cII gene in lambda.
60 In
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contrast to what has been seen with oligo-mediated recombina-
tion in bacteria, both complementary oligos were equally efficient
in promoting recombination, perhaps reflecting the rolling circle
replication employed by this phage.
When a dsDNA substrate is used, a PCR product with 50 base
pairs of homology (at each end) to a target in the phage chro-
mosome is created following the strategy outlined in Figure2.
It should be noted that drug resistance markers can only be
used if selection is going to be done in the lysogen, since these
markers cannot be employed in lytically replicating phages. Care
should be taken if a plasmid is utilized as the template in the
PCR reaction used to generate the substrate, because any residual
plasmid in the reaction products will transform the cells effici-
ently, generating undesirable background. Digestion of the PCR
reaction with DpnI (this will not cut the PCR product but will
cleave the plasmid if it was purified from a Dam+ host) can be
used to reduce the residual plasmid.
Oppenheim et al.
60 used this system to precisely replace the
rexA and rexB genes in lambda with a gene conferring ampicillin
resistance. The substrate to target the lambda chromosome was
generated as described in Figure2. In this case, a phage lysate was
grown from the electroporation mix and used to form lysogens in
naïve E. coli. Amp
R lysogens were selected, and the replacement of
the rexAB genes was confirmed by PCR.
If, as an alternative, recombinant lysogens of a complete
prophage (carrying for example, a drug resistance marker) are
going to be selected, the electroporation mixture can be spread
on a filter that is placed on top of a plate of rich nonselective
medium. After incubation for a few hours the filter is transferred
to a plate containing the selective drug. After overnight growth,
Figure1. E. coli phage recombineering. Schematic representation of the strategy used to construct and screen phage mutants by recombineering in E.
coli. If the phage to be modified is not already present as a prophage in the genome, the cells are infected with phage; subsequently, recombination
functions are expressed, and cells are made electrocompetent. The substrate is introduced into the infected cells by electroporation (dsDNA, ssDNA
containing a deletion D, or a point mutation *), and cultures are recovered to allow phage assembly. The recombinant lysate is then screened for the
desired mutant. Plating properties of the recombinant lysate can be compared with a control lysate obtained using the same protocol but without
addition of the substrate. The double-layer bacterial lawn technique can be used when a strain that supports amplification of the mutant phage (that
cannot replicate in the isogenic strain) is available. Alternatively, the desired mutant can be screened by plaque hybridization using a probe that can only
hybridize to the mutant but not to the wt phage. After the mutant phage is identified and purified, a stock can be prepared, and the presence of the
desired mutation corroborated by PCR or DNA sequencing.
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recombinants cells will give rise to colonies, and prophages can be
excised to recover mutant phage particles.
When a lytically propagated phage genome is the target,
the recombinant lysate has to be plated for direct selection of the
plaques or for further screening. Preliminarily, dilutions of the
control and recombinant lysates can be plated on lawns of a
bacterial indicator to compare plating properties of both lysates
(Fig.1). If available, a selective indicator strain should be used.
For example, if an amber mutation is introduced in an essential
gene, the double-layer bacterial lawn technique
63 can be used to
identify phages that carry the mutation. In this case, a double-
layer containing two different indicator strains is utilized to plate
the recombinant lysate. The lower layer contains the restrictive
host where only the wild-type (wt) phage can multiply, and the
top layer contains a suppressor strain that supports growth of
both the mutant and wt phage. Amber mutants can only lyse the
suppressor strain and thus form “cloudy” plaques because the
non-suppresor strain can grow to confluence (Fig.1).
If phage mutants cannot be selected or distinguished visually, a
plaque hybridization assay can be used to detect the mutant phage
derivatives (Fig.1). In order to identify the mutant, at least a
15 bp DNA sequence that is present in the recombinant phage,
but not in the original phage, is needed to use as a target for the
probe.
5 To corroborate the presence of the desired mutation, an
isolated plaque can be resuspended in buffer and used directly as
a template in a PCR reaction, using two primers that flank the
deletion/insertion.
15,52 An amplicon of differential size is expected
in the mutant as compared with the parent phage. MAMA-PCR
(mismatch amplification mutation assay PCR) can also be used to
screen for point mutations.
64 If a point mutation that alters a
restriction site was generated, the base change can be identified
after restriction of the amplified PCR product and visualization
by gel electrophoresis. Finally, a lysate of the corroborated
recombinant phage can be prepared and used for further studies.
Construction of Mycobacteriophage Mutants
by Recombineering
Mycobacteriophages—viruses that infect mycobacteria—have
been instrumental in overcoming the many challenges of per-
forming genetic studies in the human pathogen, M. tuberculosis.
These formed the basis for the development of shuttle phasmids,
65
and have been used for transposon mutagenesis,
66 reporter gene
delivery,
67-69 and specialized transduction,
70 as well as for the
construction of integration-proficient vectors, enabling the stable
introduction of foreign genes into this bacterium.
42,43,71-73 How-
ever, although mycobacteriophages have been instrumental in the
development of techniques for mycobacterial mutant construc-
tion, genetic tools enabling mutagenesis of the phages themselves
have been lacking.
In general, constructing mutant derivatives of bacteriophages
is more challenging than manipulating the bacterial host
chromosome, mostly because antibiotic selection is not useful in
lytically propagated viruses. To circumvent this, mycobacterial
recombineering could be employed for the manipulation of
prophages, which are integrated into the host chromosome, in a
manner similar to that described for the manipulation of lambda
prophages above. Unfortunately, relatively few mycobacterio-
phages form stable lysogens, significantly limiting the use of this
strategy. Until recently, the most powerful method for manip-
ulating lytic mycobacteriophages was through the use of shuttle
phasmids
74—phage-plasmid hybrids that can be packaged into
phage l particles and propagated in E. coli. In one example, this
strategy was used to make defined mutations in the tape measure
Figure2. Type of substrates used in phage recombineering. (A) ssDNA oligos (70 nt) containing either a small deletion (D) or a point mutation (*) in the
center, and which will anneal to the lagging strand template during DNA replication. (B) When the mutation is going to be constructed in a prophage,
the target gene can be replaced by an antibiotic resistance marker (ab
R). In this case, primers that amplify the resistance marker and contain about 50
bases with homology to each side of the target gene are used to generate the dsDNA substrate. (C) Schematic representation of the strategy used to
increase the homology to the target by PCR. A 200 bp substrate can be obtained from a 100-mer oligonucleotide with 50 bases of homology to each side
of the deletion and two 72-mers. In (A–C) each, blue and green rectangles indicate the homology regions to or flanking the target gene.
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gene of a shuttle phasmid derivative of mycobacteriophage TM4
by performing the mutagenesis in E. coli (by l Red recombineer-
ing) and recovering the mutant phage in M. smegmatis.
15 In spite
of this, and the obvious advantages of this technique, use of
mycobacteriophage phasmids remains limited. This is due, in
part, to the multiple steps required to construct the phasmids,
but is primarily a function of the relatively small packaging
capacity (less than ~50 kb) of l capsids, as compared with the
large average size of mycobacteriophage genomes (~70 kb).
40,41
Thus, most mycobacteriophage genomes are too large for shuttle
phasmid construction, and this approach is not broadly applicable
for functional genomic studies on this phage population.
In contrast, mycobacterial recombineering systems offer a
new, potentially powerful approach to constructing mutants of
any lytically growing mycobacteriophage, using a method termed
Bacteriophage Recombineering of Electroporated DNA (BRED),
52
the general scheme of which is illustrated in Figure3. A critical
aspect of this technique is based on the observation that, in
mycobacteria, recombineering frequencies appear to be primarily
limited by relatively poor DNA uptake efficiencies
75; that is,
even for electrocompetent mycobacteria, only 1 out of 1000
viable cells can productively take up DNA. This presents a
challenge when constructing mutations for which there is no
selection, such as chromosomal point mutations with no known
phenotype, as 99.9% colonies recovered will arise from cells that
were unable to take up the recombineering substrate.
47 The issue
is circumvented in ssDNA recombineering by employing a
counter-selection strategy, in which a selectable plasmid (or a
second oligonucleotide that incorporates a selectable point
mutation) is co-transformed with the ssDNA substrate.
6,7 This
effectively selects against non-competent cells in the population,
and the transformants can then be screened for the mutation
using MAMA-PCR,
10,64 which selectively amplifies the mutant
allele. In this way, non-selectable mutations can be easily
recovered due to the high efficiency of ssDNA recombineering.
The technique described in the previous section for the recom-
bineering of an E. coli phage, such as l, involves infecting with
the phage to be targeted, inducing the recombineering func-
tions, and electroporating with the DNA substrate;
60 however,
the inefficiency of DNA uptake in mycobacteria precludes this
approach. Therefore, in BRED, we have adopted an alternative
approach derived from the co-selection methods described
above.
52 In this procedure, an M. smegmatis strain carrying a
recombineering plasmid is induced with acetamide, and electro-
competent cells are prepared. This electroporation is performed
with both the genomic DNA of the phage to be manipulated and
a PCR-generated or synthetic DNA substrate that targets this
phage (Fig.2). After a brief recovery period, the reactions are
mixed with additional plating cells of M. smegmatis and plated as
in an infectious center assay (i.e., prior to lysis, such as plaques
are generated from infected cells, not from viral particles). In this
way, only cells that have taken up phage DNA will give rise to
plaques within the bacterial lawn, effectively selecting against
those that are non-transformable; on average, about 100 plaques
are obtained from 50–100 ng of phage DNA in such an
experiment. All of these primary plaques will contain wild-type
Figure3. Mycobacteriophage recombineering. Schematic representation
of the strategy used to construct phage mutants in Mycobacterium
smegmatis by recombineering. M. smegmatis cells inducibly expressing
the recombination functions are co-electroporated with phage DNA and
the recombineering substrate; these are mixed with M. smegmatis
plating cells and plated to obtain individual plaques. Primary plaques are
screened by PCR with flanking primers to detect those containing
mutant phage that is present at some frequency in combination with the
wt phage. Once identified in this way, a positive plaque containing the
mutant allele will be diluted and plated. If a non-essential gene was
targeted, the mutant phage can be easily identified by PCR. Essentiality
of the target gene can be inferred if the mutant allele is not detected in a
lysate of pooled secondary plaques.
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phage DNA, and a subset (5–50%) will also contain the mutant
allele,
52 which can be readily identified by PCR screening.
Provided the mutation does not ablate a region that is essential for
phage growth, purified mutant phage derivatives can be isolated
by plating serial dilutions of the mixed plaques, followed by
purification and PCR analysis of the resulting secondary plaques.
The frequency with which the pure mutants are recovered can
vary significantly depending on factors such as the amount of
mutant allele present in the primary plaque and the phenotype
of the mutant (e.g., it will be recovered at a lower frequency if
it has a reduced burst size as compared with wild-type). Often,
analysis of 12–18 secondary plaques is sufficient to identify a
homogenously mutant strain, but in other cases, it has been
necessary to screen secondary plaques in pools of 5–10 in order
to recover the mutant. In these cases, once a pool containing
the mutant is identified, a third plating is necessary to completely
purify the mutant. This pooling strategy essentially enriches for
a mutation that might have been present at very low levels in the
initial primary plaque.
To date, the most common application for BRED has been
the construction of unmarked gene deletions; however, this
technique can also be used to efficiently engineer in-frame inter-
nal deletions, small insertions, point mutations and gene replace-
ments in the phage genome, none of which require selection
for mutant recovery
52 (Hatfull Lab, unpublished data). When
constructing a deletion or insertion mutant, a 200 bp dsDNA
substrate, having 100 bp of homology flanking the region to be
deleted or inserted is recommended, as a higher proportion of
primary plaques contain the desired mutant allele when using
dsDNA vs. ssDNA substrates, and larger substrates (200 bp) vs.
shorter ones (100 bp). Insertions are typically screened
by PCR using one primer that anneals within the
inserted region and another that anneals to a down-
stream region in the phage chromosome. For deletions,
primers that flank the deleted region are used; when
the mutant allele is present in a primary plaque, these
produce a smaller PCR product that is most often
easily visible on an agarose gel. In some cases—usually
when the mutants are somewhat defective—mutant
alleles are present at low frequencies in the primary
plaques and cannot be detected by flanking primers.
For these situations, we have adapted the MAMA-PCR
strategy described above and developed a technique
termed Deletion Amplification Detection Assay
(DADA) PCR.
52 This employs a DADA-PCR primer
that anneals across the new junction created by the
deletion at its 3' end and another that anneals to
the flanking DNA, either up- or downstream of this.
The DADA-PCR primer is designed such that in the
mutant allele, the primer will anneal perfectly across
the deletion site (this is the site created by the joining
of the two DNA ends that flank the deleted region),
but in the wild-type phage, the terminal one to three 3'
nucleotides (depending on the primer design) will not
base pair with the DNA template (Fig.4). A high fide-
lity DNA polymerase will have difficulty synthesizing
through this mismatch, and thus, under stringent conditions, the
wild-type allele is not amplified.
One application of BRED in which the DADA-PCR detec-
tion strategy has been quite useful is in the deletion of genes
that are essential—or suspected to be essential—for phage growth.
We have been able to delete a number of essential genes in
mycobacteriophage Giles (such as the lysin A)
52 (Hatfull lab,
unpublished data) and other phages by constructing a comple-
mentation strain of M. smegmatis for mutant isolation, which
expresses the phage gene to be deleted. In these cases, it is often
necessary to use DADA-PCR to detect primary plaques contain-
ing the mutant allele. These can be recovered on wild-type
bacteria, presumably due to the presence of wild-type helper
phage in the primary plaque. Once such a plaque is recovered,
essentiality can be inferred if the mutant allele is not detected
in lysates prepared from a re-plating of these mixed plaques on
wild-type cells; that is, the individual mutant particles could not
give rise to plaques in the secondary plating. The mixed primary
plaque must then be serially diluted and plated on the comple-
mentation strain. Secondary plaques are picked and patched in
duplicate on wild-type and complementing bacteria, and a mutant
phage can be identified as one that is only able to infect and
kill the complementing M. smegmatis. This strategy provides a
powerful and effective way to screen for gene essentially, allowing
us to determine which of the many unique genes found in the
mycobacteriophages are required for lytic growth.
Another type of genetic manipulation for which BRED has
proved successful is the engineering of point mutations, and for
this, ssDNA synthetic substrates are employed.
52 Although an
extensive length dependence analysis has not been performed,
Figure4. Deletion Amplification Assay (DADA) PCR. DADA-PCR is used to specifically
detect the presence of a gene deletion allele that is present at a low frequency or is
otherwise difficult to detect in a mixed population of mutant and WT phage. The
DADA-PCR primer is designed such that the 3’ end anneals across the new junction
created by the joining of the two DNA ends flanking the deleted region. When this
primer anneals to the WT allele, this creates mismatch (shown an ‘x’ in the figure)
through which a high fidelity DNA polymerase cannot synthesize under stringent
PCR conditions. However, the DADA-PCR primer is complementary to the deletion
allele, and with an appropriate down- (or up-) stream primer, will only generate a
product if the mutant allele is present.
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we find that oligonucleotides that are at least 71 nt in length are
sufficient to efficiently recover the mutation (Marinelli, unpub-
lished data). Based on the observations from mycobacterial
ssDNA recombineering
47; however, it is possible that shorter
substrates might also work well. Importantly, due to the nature of
phage DNA replication, when constructing point mutations, oligo-
nucleotides targeting both strands are used and are transformed
together with the phage genomic DNA.
52 The primary and
secondary plaques are screened for the mutant allele using MAMA-
PCR and purified using the same techniques outlined above.
Finally, we have shown that BRED can be used for the con-
struction of gene replacement mutants within the phage genome.
52
As mentioned above, antibiotic resistance cassettes are not useful
in lytic phages; however, numerous other applications—such as
the construction of fluorescent reporter phages
67-69—could be
envisioned for which it would be desirable to insert a foreign
gene into a phage genome. The fairly strict packaging size con-
straints that exist for dsDNA bacteriophages would necessitate
inserting a gene such as egfp (enhanced green fluorescent protein)
in place of a similarly sized non-essential phage gene. For this
type of BRED, we use dsDNA substrates, synthesized by PCR,
that contain the cassette of choice flanked by 100 bp homolog-
ous to either end of the target gene that is being replaced. Such
mutations are easily detected using a primer pair in which one
anneals within the newly inserted gene and the other anneals to
a region up- or downstream within the phage genome.
To date, BRED has been successfully used on nine different
mycobacteriophages
52,76-78 (Hatfull Lab, unpublished data), and it
is likely that the full utility of these approaches for mycobacter-
iophage mutagenesis has yet to be realized. For example, the
coupling of efficient point mutagenesis with mycobacterial non-
sense suppressor strains
79 could provide a relatively simple method
for making conditional lethal mutants in mycobacteriophage
genomes. It might also be possible to utilize this technique for the
manipulation of phages that infect other species of mycobacteria
or those infecting other closely related bacteria.
Perspectives
Coordinated efforts spanning the last decade have yielded a vast
collection of fully sequenced bacteriophages. About 600 fully
sequenced and annotated bacteriophage genomes are available
from the NCBI database, revealing a genetically diverse popula-
tion of architecturally mosaic genomes. This immense reservoir
of genetic information has created numerous opportunities for
functional genomic studies aimed at uncovering novel functions
within this phage population.
Just for Mycobacteriophages alone, an enormous number
of predicted open reading frames of unknown function have
been found, which make up over 3,000 phamilies of unique
genes having no detectable sequence similarity to known
proteins.
41-45,73,80 An increasing interest in the hunt for phage
proteins that can promote recombination functions has been
particularly driven by the number of bacteriophage genome
sequences available.
50 These functions can potentially be used
to develop species-specific recombineering systems in a diverse
suite of organisms.
Bacteriophage recombineering has shown to be a highly
effective approach for the construction of gene deletions, small
insertions, gene replacements, and point mutations in lytically
replicating phages.
52,60 This technique will, for the first time,
allow us to perform broad functional genomic studies on bac-
teriophages, potentially revealing new and exciting features of
this diverse phage population.
Here we have described the modification of E. coli phages
and mycobacteriophages. However, with slight modifications to
these protocols, and providing the appropriate recombination
systems are found, these methods can potentially be adapted for
use with many other phages. Any new bacteriophage isolated can
be a possible source for new recombination proteins. For this
purpose, genetic manipulation of these phages could be very
useful and recombineering could become the perfect ally to
accomplish this objective. Thus, bacteriophage recombineering
will not only facilitate the study of orphan genes and provide
insights into phage biology, but also could help to uncover
new and valuable instruments for the manipulation of genetically
naive bacteria.
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